0001317757-12-000007.txt : 20120110 0001317757-12-000007.hdr.sgml : 20120110 20120110164327 ACCESSION NUMBER: 0001317757-12-000007 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120109 FILED AS OF DATE: 20120110 DATE AS OF CHANGE: 20120110 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Farmer Joseph L CENTRAL INDEX KEY: 0001317757 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-10865 FILM NUMBER: 12520393 MAIL ADDRESS: STREET 1: C/O AMAG PHARMACEUTICALS, INC. STREET 2: 100 HAYDEN AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMAG PHARMACEUTICALS INC. CENTRAL INDEX KEY: 0000792977 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 042742593 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 HAYDEN AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 6174983300 MAIL ADDRESS: STREET 1: 100 HAYDEN AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 FORMER COMPANY: FORMER CONFORMED NAME: ADVANCED MAGNETICS INC DATE OF NAME CHANGE: 19920703 4/A 1 primary_doc.xml PRIMARY DOCUMENT X0304 4/A 2012-01-09 2012-01-10 0 0000792977 AMAG PHARMACEUTICALS INC. AMAG 0001317757 Farmer Joseph L C/O AMAG PHARMACEUTICALS, INC. 100 HAYDEN AVENUE LEXINGTON MA 02421 0 1 0 0 SVP, General Counsel Common Stock 2012-01-09 4 C 0 8000 A 8000 D Common Stock 2012-01-09 4 S 0 8000 17.0924 D 0 D Restricted Stock Units 2012-01-09 4 C 0 8000 A Common Stock 8000 8000 D The shares were acquired by the reporting person as a result of the partial vesting of a restricted stock unit grant described below. Not applicable. The sales reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. The shares sold on this date were sold in multiple transactions. The price is the weighted average sales price per share of all shares sold on this day. The actual sales prices range from $16.40-$17.955. Upon request by the Securities and Exchange Commission, the issuer, or any security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each price. Each restricted stock unit represents a contingent right to receive one share of common stock. Grant of restricted stock unit pursuant to the AMAG Pharmaceuticals, Inc. Second Amended and Restated 2007 Equity Incentive Plan. This grant vests as follows: 50% on January 7, 2012, 25% on January 7, 2013 and the remaining 25% on January 7, 2014. Joseph L. Farmer 2012-01-10